These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23397951)

  • 1. Mutations of the BRAF gene in human cancer, by Davies et al. (Nature 2002; 417: 949-54).
    Millington GW
    Clin Exp Dermatol; 2013 Mar; 38(2):222-3. PubMed ID: 23397951
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of exon 15 BRAF germline mutations in familial melanoma.
    Lang J; Boxer M; MacKie R
    Hum Mutat; 2003 Mar; 21(3):327-30. PubMed ID: 12619120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missense mutations of the BRAF gene in human lung adenocarcinoma.
    Naoki K; Chen TH; Richards WG; Sugarbaker DJ; Meyerson M
    Cancer Res; 2002 Dec; 62(23):7001-3. PubMed ID: 12460919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of constitutively active V599EBRaf.
    Andersen MH; Fensterle J; Ugurel S; Reker S; Houben R; Guldberg P; Berger TG; Schadendorf D; Trefzer U; Bröcker EB; Straten Pt; Rapp UR; Becker JC
    Cancer Res; 2004 Aug; 64(15):5456-60. PubMed ID: 15289355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
    Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
    Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant form of BRAF gene in blood plasma of cancer patients.
    Vdovichenko KK; Markova SI; Belokhvostov AS
    Ann N Y Acad Sci; 2004 Jun; 1022():228-31. PubMed ID: 15251965
    [No Abstract]   [Full Text] [Related]  

  • 7. Loitering with intent: new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions.
    Smalley KS; Herlyn M
    J Invest Dermatol; 2004 Oct; 123(4):xvi-xvii. PubMed ID: 15373800
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations of the BRAF gene in benign and malignant melanocytic lesions.
    Yazdi AS; Palmedo G; Flaig MJ; Puchta U; Reckwerth A; Rütten A; Mentzel T; Hügel H; Hantschke M; Schmid-Wendtner MH; Kutzner H; Sander CA
    J Invest Dermatol; 2003 Nov; 121(5):1160-2. PubMed ID: 14708620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF alterations are associated with complex mutational profiles in malignant melanoma.
    Daniotti M; Oggionni M; Ranzani T; Vallacchi V; Campi V; Di Stasi D; Torre GD; Perrone F; Luoni C; Suardi S; Frattini M; Pilotti S; Anichini A; Tragni G; Parmiani G; Pierotti MA; Rodolfo M
    Oncogene; 2004 Aug; 23(35):5968-77. PubMed ID: 15195137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray expression profiling in melanoma reveals a BRAF mutation signature.
    Pavey S; Johansson P; Packer L; Taylor J; Stark M; Pollock PM; Walker GJ; Boyle GM; Harper U; Cozzi SJ; Hansen K; Yudt L; Schmidt C; Hersey P; Ellem KA; O'Rourke MG; Parsons PG; Meltzer P; Ringnér M; Hayward NK
    Oncogene; 2004 May; 23(23):4060-7. PubMed ID: 15048078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lucky draw in the gene raffle.
    Pollock PM; Meltzer PS
    Nature; 2002 Jun; 417(6892):906-7. PubMed ID: 12087387
    [No Abstract]   [Full Text] [Related]  

  • 12. BRAF point mutations in primary melanoma show different prevalences by subtype.
    Sasaki Y; Niu C; Makino R; Kudo C; Sun C; Watanabe H; Matsunaga J; Takahashi K; Tagami H; Aiba S; Horii A
    J Invest Dermatol; 2004 Jul; 123(1):177-83. PubMed ID: 15191558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF as a potential therapeutic target in melanoma and other malignancies.
    Tuveson DA; Weber BL; Herlyn M
    Cancer Cell; 2003 Aug; 4(2):95-8. PubMed ID: 12957284
    [No Abstract]   [Full Text] [Related]  

  • 14. BRAF as a melanoma susceptibility candidate gene?
    Laud K; Kannengiesser C; Avril MF; Chompret A; Stoppa-Lyonnet D; Desjardins L; Eychene A; Demenais F; Lenoir GM; Bressac-de Paillerets B;
    Cancer Res; 2003 Jun; 63(12):3061-5. PubMed ID: 12810628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutations in metastatic melanoma: a possible association with clinical outcome.
    Kumar R; Angelini S; Czene K; Sauroja I; Hahka-Kemppinen M; Pyrhönen S; Hemminki K
    Clin Cancer Res; 2003 Aug; 9(9):3362-8. PubMed ID: 12960123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study.
    Casula M; Colombino M; Satta MP; Cossu A; Ascierto PA; Bianchi-Scarrà G; Castiglia D; Budroni M; Rozzo C; Manca A; Lissia A; Carboni A; Petretto E; Satriano SM; Botti G; Mantelli M; Ghiorzo P; Stratton MR; Tanda F; Palmieri G;
    J Clin Oncol; 2004 Jan; 22(2):286-92. PubMed ID: 14722037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF mutations in conjunctival melanoma.
    Gear H; Williams H; Kemp EG; Roberts F
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2484-8. PubMed ID: 15277467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
    Dong J; Phelps RG; Qiao R; Yao S; Benard O; Ronai Z; Aaronson SA
    Cancer Res; 2003 Jul; 63(14):3883-5. PubMed ID: 12873977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
    Tsao H; Goel V; Wu H; Yang G; Haluska FG
    J Invest Dermatol; 2004 Feb; 122(2):337-41. PubMed ID: 15009714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant.
    Tsavachidou D; Coleman ML; Athanasiadis G; Li S; Licht JD; Olson MF; Weber BL
    Cancer Res; 2004 Aug; 64(16):5556-9. PubMed ID: 15313890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.